US58933Y1055
US58933Y1055
Merck & Company, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 359.22B EUR | 317.22B EUR | 297.08B EUR | 260.48B EUR |
Enterprise Value | 398.1B EUR | 364.28B EUR | 340.87B EUR | 295.25B EUR |
Valuation Multiples | ||||
Trailing P/E | 115.56x | 99.97x | 33.25x | 19.77x |
Forward P/E | 15.38x | -- | -- | -- |
Price to Sales | 5.4x | 4.77x | 4.52x | 5.26x |
Price to Book | 8.57x | 7.56x | 6.48x | 4.95x |
EV/Revenue | 5.98x | 5.47x | 5.18x | 5.97x |
EV/EBITDA | 13.79x | 24.86x | 16.84x | 13.59x |
Price to FCF (P/FCF) | 23.68x | 19.75x | 21.05x | 23.28x |
EV/FCF | 26.24x | 22.68x | 24.15x | 26.39x |
FCF Yield | 4.22% | 5.06% | 4.75% | 4.3% |